Michael Färber

483 total citations
7 papers, 335 citations indexed

About

Michael Färber is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Färber has authored 7 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Färber's work include Gastrointestinal Tumor Research and Treatment (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Michael Färber is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Michael Färber collaborates with scholars based in United States, Canada and Germany. Michael Färber's co-authors include Barry R. Davis, Hendrik Manner, Christian Ell, Johannes Kunz, Insa Aschmoneit, E. Lotterer, O Möschler, Klaus Mönkemüller, Andrea May and Liebwin Goßner and has published in prestigious journals such as Circulation, Hypertension and The American Journal of Gastroenterology.

In The Last Decade

Michael Färber

7 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Färber United States	4	160	158	139	49	21	7	335
Yuk–Kong Lau China	10	246 1.5×	133 0.8×	105 0.8×	33 0.7×	46 2.2×	11	376
Stephen Voyce United States	6	127 0.8×	50 0.3×	29 0.2×	11 0.2×	30 1.4×	20	202
Lewis Bs Israel	11	200 1.3×	200 1.3×	108 0.8×	11 0.2×	67 3.2×	47	406
Faraj Kargoli United States	11	235 1.5×	94 0.6×	15 0.1×	15 0.3×	24 1.1×	35	345
Nadia Guidozzi United Kingdom	5	33 0.2×	196 1.2×	40 0.3×	20 0.4×	50 2.4×	10	277
Akie Shimada Japan	10	137 0.9×	63 0.4×	6 0.0×	21 0.4×	60 2.9×	35	285
Asım Çingi Türkiye	12	18 0.1×	221 1.4×	25 0.2×	29 0.6×	76 3.6×	32	329
S. Saravana Kumar United States	11	28 0.2×	211 1.3×	61 0.4×	16 0.3×	35 1.7×	33	260
Norbert Donner-Banzhoff Germany	9	159 1.0×	62 0.4×	17 0.1×	5 0.1×	25 1.2×	12	261
Bastiaan Zwart Netherlands	7	323 2.0×	263 1.7×	6 0.0×	47 1.0×	29 1.4×	21	377

Countries citing papers authored by Michael Färber

Since Specialization

Citations

This map shows the geographic impact of Michael Färber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Färber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Färber more than expected).

Fields of papers citing papers by Michael Färber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Färber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Färber. The network helps show where Michael Färber may publish in the future.

Co-authorship network of co-authors of Michael Färber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Färber. A scholar is included among the top collaborators of Michael Färber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Färber. Michael Färber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Färber, Michael, et al.. (2011). 434 A Comparison of High Dose Insulin Therapy and Conventional Inotropic Therapy in Calcium Channel Blocker And/or Beta-Blocker Toxic Ingestions. Annals of Emergency Medicine. 58(4). S325–S325. 3 indexed citations

May, Andrea, Michael Färber, Insa Aschmoneit, et al.. (2010). Prospective Multicenter Trial Comparing Push-and-Pull Enteroscopy With the Single- and Double-Balloon Techniques in Patients With Small-Bowel Disorders. The American Journal of Gastroenterology. 105(3). 575–581. 145 indexed citations

Davis, Barry R., Lara M. Simpson, Charles E. Ford, et al.. (2009). Response to Letter Regarding Article, “Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial”. Circulation. 120(5). 1 indexed citations

May, Andrea, Michael Färber, Insa Aschmoneit, et al.. (2009). Prospective Multicenter Trial Comparing Double Balloon Enteroscopy (DBE) and Single Balloon Enteroscopy (SBE) in Patients with Suspected Small Bowel Disorder. Gastrointestinal Endoscopy. 69(5). AB127–AB127. 2 indexed citations

Davis, Barry R., John B. Kostis, Lara M. Simpson, et al.. (2008). Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation. 118(22). 2259–2267. 134 indexed citations

Pressel, Sara, Barry R. Davis, Gail T. Louis, et al.. (2001). Participant Recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Controlled Clinical Trials. 22(6). 674–686. 31 indexed citations

Taylor, Jennifer, Nemat O. Borhani, George Entwisle, Michael Färber, & C. Hawkins. (1983). Hypertension detection and follow-up program. Summary of the baseline characteristics of the hypertensive participants.. Hypertension. 5(6_pt_2). IV44–50. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact